PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 6:49 AM ET

Sponsor Check › Person

AD
No photo found yet (own website and image search run after this page is viewed)

Alan Dean

Named as an officer, director or promoter on SEC Form D filings · TX · Jan 14, 2010 → Mar 16, 2018

6deals (issuers)
$88.8Mreported sold
276investors
27Form D filings
2010–2018years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Alan Dean is listed as a director and promoter on 27 SEC Form D filings by 6 issuers between Jul 2009 and Mar 2018. Largest by amount reported sold: Targeted Technology Fund II, LP (San Antonio, TX — pooled investment fund — 2013–2014; $37.2M reported sold to 83 investors), CytoBioscience, Inc. (San Antonio, TX — biotechnology — 2015–2018; $15.8M reported sold to 11 investors), BI02 MEDICAL, INC. (Helotes, TX — biotechnology — 2010–2017; $11.9M reported sold to 66 investors), TARGETED TECHNOLOGY FUND I, LP (San Antonio, TX — pooled investment fund — 2009–2010; $11.2M reported sold to 48 investors), Viroxis Corp (San Antonio, TX — pharmaceuticals — 2010–2013; $7.79M reported sold to 43 investors) and 1 more (all listed below).

What this means A repeat sponsor — 6 separate companies raised money with this person listed as director and promoter, over about 9 years. Across those companies the filings report $88.8M sold in total.

Listed alongside Paul Castella (24 shared filings), Ian Clements (14 shared filings), Christopher Banas (12 shared filings), James F. Traa (8 shared filings), Luis Angel (7 shared filings) and 18 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Alan. Each name links to their own page.

The issuers belong to 2 sponsor groups: Targeted Technology (9 issuers, $64.9M reported sold, 2009–2026) and Stembiosys (2 issuers, $1.53M reported sold, 2013–2020).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 12 bankruptcy cases matching the name listed in Key records below.

What this means 12 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 27 public filings for Alan Dean and found 12 differences, 1 worth asking the sponsor about: Form D filed 176 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Alan Dean has not run yet — it is joining a line of 20,319 names; searches run around the clock at the hosts' allowed rate. Searched so far: 297 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: NV (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Alan Dean..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for IA, IN, KS, MI, NE, NV (see docs/state-regulators.md).

3. Bankruptcies

12 cases: 12 closed (disposition not in docket feed)

Alan L. Dean and Barbara A. Dean closed
United States Bankruptcy Court, N.D. Iowa · No. 18-00795 · Filed Jun 11, 2018 · Closed Dec 26, 2019
Role of Alan L. Dean and Barbara A. Dean: Debtor · Outcome: Case closed 2019-12-26 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in IA (not a filing state)
Alan L. Dean closed
United States Bankruptcy Court, D. Utah · No. 14-22428 · Filed Mar 14, 2014 · Closed Sep 22, 2014
Role of Alan L. Dean: Debtor · Outcome: Case closed 2014-09-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in UT (not a filing state)
Alan L Dean closed
United States Bankruptcy Court, C.D. California · No. 6:13-bk-13114 · Filed Feb 22, 2013 · Closed Jun 4, 2013
Role of Alan L Dean: Debtor · Outcome: Case closed 2013-06-04 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in CA (not a filing state)
Alan H Dean and Shannon S Dean closed
United States Bankruptcy Court, M.D. Florida · No. 3:10-bk-03366 · Filed Apr 22, 2010 · Closed Feb 28, 2012
Role of Alan H Dean and Shannon S Dean: Debtor · Outcome: Case closed 2012-02-28 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in FL (not a filing state)
Alan E. Dean closed
United States Bankruptcy Court, E.D. Michigan · No. 09-34757 · Filed Sep 4, 2009 · Closed Jan 29, 2010
Role of Alan E. Dean: Debtor · Outcome: Case closed 2010-01-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in MI (not a filing state)
Alan L Dean closed
United States Bankruptcy Court, N.D. Indiana · No. 08-30950 · Filed Mar 31, 2008 · Closed Jul 30, 2008
Role of Alan L Dean: Debtor · Outcome: Case closed 2008-07-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in IN (not a filing state)
Alan L. Dean closed
United States Bankruptcy Court, D. Massachusetts · No. 05-49318 · Filed Oct 14, 2005 · Closed Feb 3, 2006
Role of Alan L. Dean: Debtor · Outcome: Case closed 2006-02-03 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in MA (not a filing state)
Alan R. Dean closed
United States Bankruptcy Court, S.D. Illinois · No. 04-60742 · Filed Jul 2, 2004 · Closed Oct 29, 2004
Role of Alan R. Dean: Debtor · Outcome: Case closed 2004-10-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in IL (not a filing state)
Alan A. Dean closed
United States Bankruptcy Court, D. Connecticut · No. 03-22280 · Filed Jul 21, 2003 · Closed Sep 14, 2004
Role of Alan A. Dean: Debtor · Outcome: Case closed 2004-09-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in CT (not a filing state)
Alan J. Dean and Annette Marie Dean closed
United States Bankruptcy Court, D. Maryland · No. 03-59211 · Filed Jun 4, 2003 · Closed Feb 17, 2004
Role of Alan J. Dean and Annette Marie Dean: Debtor · Outcome: Case closed 2004-02-17 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in MD (not a filing state)
Tresia Shirl Dean and Alan L. Dean closed
United States Bankruptcy Court, W.D. Arkansas · No. 3:03-bk-73525 · Filed May 23, 2003 · Closed Aug 27, 2003
Role of Alan L. Dean: Debtor · Outcome: Case closed 2003-08-27 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in AR (not a filing state)
Alan L. Dean and Barbara A. Dean closed
United States Bankruptcy Court, N.D. Iowa · No. 94-51898 · Filed Nov 22, 1994 · Closed Jun 21, 1995
Role of Alan L. Dean and Barbara A. Dean: Debtor · Outcome: Case closed 1995-06-21 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 30 federal dockets); 2 people with this name in Form D filings; court in IA (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for Alan Dean — 1 worth asking about (compared 27 filings on Oct 24, 2026)

Note · Jul 14, 2009 – Mar 16, 2018

7 filings report more than 10% of the money raised going to insiders

16% of the money raised went to insiders — CytoBioscience, Inc. · 16% of the money raised went to insiders — CytoBioscience, Inc. · 22% of the money raised went to insiders — TARGETED TECHNOLOGY FUND I, LP · 22% of the money raised went to insiders — TARGETED TECHNOLOGY FUND I, LP · 22% of the money raised went to insiders — TARGETED TECHNOLOGY FUND I, LP · and 2 more

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D/A · Mar 16, 2018 ↗CytoBioscience, Inc. — PartnerFacts page ↗Form D · Mar 15, 2018 ↗Form D/A · Jan 13, 2010 ↗
Sources
Note · Jan 13, 2010

Alan Dean appears on 1 deal that stopped filing before reaching its target

TARGETED TECHNOLOGY FUND I, LP (last filing Jan 13, 2010; $11,235,000 sold of $50,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

TARGETED TECHNOLOGY FUND I, LP — PartnerFacts page ↗
Sources
Worth asking · May 21, 2014 – Nov 13, 2014

Form D filed 176 days after the first sale — Bluegrass Vascular Technologies, Inc.

The filing says the first sale was May 21, 2014. The Form D was filed Nov 13, 2014 — 176 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 161 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Nov 13, 2014 ↗Bluegrass Vascular Technologies, Inc. — PartnerFacts page ↗
Sources
Note · Oct 1, 2010 – Oct 18, 2010

Form D filed 17 days after the first sale — Viroxis Corp

The filing says the first sale was Oct 1, 2010. The Form D was filed Oct 18, 2010 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Oct 18, 2010 ↗Viroxis Corp — PartnerFacts page ↗
Sources
Note · Jun 30, 2009 – Jan 23, 2018

12 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — CytoBioscience, Inc. (latest filing Jan 23, 2018) · No amendment in the last 12 months on an offering that may still be open — BI02 MEDICAL, INC. (latest filing Mar 31, 2017) · No amendment in the last 12 months on an offering that may still be open — BI02 MEDICAL, INC. (latest filing Jul 10, 2015) · No amendment in the last 12 months on an offering that may still be open — Bluegrass Vascular Technologies, Inc. (latest filing Nov 13, 2014) · No amendment in the last 12 months on an offering that may still be open — Targeted Technology Fund II, LP (latest filing Oct 15, 2014) · and 7 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D/A · Jan 23, 2018 ↗CytoBioscience, Inc. — PartnerFacts page ↗Form D · Mar 31, 2017 ↗BI02 MEDICAL, INC. — PartnerFacts page ↗
Sources
Note · Mar 26, 2015 – Aug 10, 2016

Offering amount changed between filings — CytoBioscience, Inc.

The Mar 26, 2015 filing says $18,000,000 offered; the Aug 10, 2016 Form D/A says $21,821,845.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Mar 26, 2015 ↗Form D/A (later) · Aug 10, 2016 ↗CytoBioscience, Inc. — PartnerFacts page ↗
Sources
Note · May 26, 2010 – Apr 11, 2013

Offering amount changed between filings — Viroxis Corp

The May 26, 2010 filing says $1,500,000 offered; the Apr 11, 2013 Form D/A says $7,795,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · May 26, 2010 ↗Form D/A (later) · Apr 11, 2013 ↗Viroxis Corp — PartnerFacts page ↗
Sources
Note · Nov 2, 2009 – Dec 23, 2009

Minimum investment changed between filings — TARGETED TECHNOLOGY FUND I, LP

The Nov 2, 2009 filing lists a minimum of $80,000; the Dec 23, 2009 Form D/A lists $10,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · Nov 2, 2009 ↗Form D/A (later) · Dec 23, 2009 ↗TARGETED TECHNOLOGY FUND I, LP — PartnerFacts page ↗
Sources
Note · Jul 14, 2009 – Jan 14, 2010

Alan Dean is written 2 different ways on the filings

listed as "Alan H. Dean" on 7 filings (from Jul 14, 2009), and "Alan Dean" on 20 filings (from Jan 14, 2010).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jul 14, 2009 ↗Form D · Jan 14, 2010 ↗Alan Dean — PartnerFacts page ↗
Sources
Note · Apr 15, 2010 – Mar 14, 2014

Reported revenue range changed between filings — BI02 MEDICAL, INC.

"No Revenues" (Apr 15, 2010); then "$1 - $1,000,000" (Mar 14, 2014).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Apr 15, 2010 ↗Form D · Mar 14, 2014 ↗BI02 MEDICAL, INC. — PartnerFacts page ↗
Sources
Note · Aug 25, 2010

Same name, different state: "Alan Dean" (AL) is a separate record

This page covers filings where the address state is TX. A separate record, "Alan Dean" with address state AL, is listed on 1 filing — most recently by BioDtech Inc (Aug 25, 2010). Both records have filings in the same period (Aug 25, 2010).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Alan Dean (AL) — PartnerFacts page ↗Form D · Aug 25, 2010 ↗BioDtech Inc — PartnerFacts page ↗Alan Dean (TX) — this page ↗
Sources
Note · Jul 10, 2015 – Mar 31, 2017

Address moved from San Antonio, TX to Helotes, TX — BI02 MEDICAL, INC.

The people listed on the Jul 10, 2015 filing give San Antonio, TX; on the Mar 31, 2017 filing they give Helotes, TX.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 10, 2015 ↗Form D · Mar 31, 2017 ↗BI02 MEDICAL, INC. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

8 of 15 offerings report sales commissions totalling $1,796,552; 0 report finder's fees; 2 report proceeds to related persons totalling $2,665,525. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 16, 2018 D/A
CytoBioscience, Inc.
File 021-307871
$90,000$0$250,000 (est.)Danielle Hughes BrokerCheck CRD 2189447 ↗
via Divine Capital Markets (CRD 118212 ↗)
EDGAR ↗
Jan 23, 2018 D/A
CytoBioscience, Inc.
File 021-236674
$137,500$0$0Jim Garvin BrokerCheck CRD 6219942 ↗
via Divine Capital Markets LLC (CRD 118212 ↗)
EDGAR ↗
Mar 31, 2017 D
BI02 MEDICAL, INC.
File 021-283782
$0$0$0
A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above.
None listed on this filingEDGAR ↗
Jul 10, 2015 D
BI02 MEDICAL, INC.
File 021-243484
$0$0$0
A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above.
None listed on this filingEDGAR ↗
Nov 13, 2014 D
Bluegrass Vascular Technologies, Inc.
File 021-228196
$0$0$0None listed on this filingEDGAR ↗
Oct 15, 2014 D/A
Targeted Technology Fund II, LP
File 021-206001
$473,350 (est.)$0$0
A portion of the proceeds will be used to pay the management fees to the general partner and the persons named in response to Item 3 above will receive a portion of the management fee.
Braymen, Lambert & Noel Securities, Ltd. BrokerCheck CRD 124902 ↗EDGAR ↗
Mar 14, 2014 D
BI02 MEDICAL, INC.
File 021-213584
$164,196$0$0
A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above.
Braymen, Lambert & Noel Securities, Ltd. BrokerCheck CRD 124902 ↗
via Braymen, Lambert & Noel Securities, Ltd. (CRD 124902 ↗)
EDGAR ↗
Apr 22, 2013 D/A
Viroxis Corp
File 021-142612
$116,750$0$0
A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above.
Braymen, Lambert & Noel Securities, Ltd. BrokerCheck CRD 124902 ↗
via Braymen, Lambert & Noel Securities, Ltd. (CRD 124902 ↗)
EDGAR ↗
Sep 5, 2012 D
BI02 MEDICAL, INC.
File 021-183661
$349,485$0$0
A portion of the proceeds will be used to pay the salaries to be paid to the person named in response toItem 3 above
Karutz Flavin Wells Investment Bankers, LLC no CRD number reported
via Braymen, Lambert and Noel Securities, Ltd. (CRD 124902 ↗)
EDGAR ↗
Mar 8, 2012 D
Viroxis Corp
File 021-174538
$0$0$0
A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above
None listed on this filingEDGAR ↗
Aug 11, 2011 D
BI02 MEDICAL, INC.
File 021-164244
$191,338 (est.)$0$0
A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above
Karutz Flavin Wells Investment Bankers, LLC no CRD number reported
via Braymen, Lambert and Noel Securities, Ltd. (CRD 124902 ↗)
EDGAR ↗
Oct 18, 2010 D
Viroxis Corp
File 021-149227
$0$0$0
A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above
None listed on this filingEDGAR ↗
May 4, 2010 D/A
BI02 MEDICAL, INC.
File 021-140621
$273,933$0$0
A portion of the proceeds will be used to pay the salaries to be paid to the persons named in response to Item 3 above
Karutz Flavin Wells Investment Bankers, LLC no CRD number reported
via BLN Securities Ltd (CRD 124902 ↗)
EDGAR ↗
Jan 14, 2010 D
Viroxis Corp
File 021-137813
$0$0$0None listed on this filingEDGAR ↗
Jan 13, 2010 D/A
TARGETED TECHNOLOGY FUND I, LP
File 021-132734
$0$0$2,415,525 (est.)
Above is an estimate of the management fee to be paid to the general partner of the Issuer over the estimated 10 year term.
None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 6

Every issuer that named Alan Dean on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

C
Biotechnology · group: Stembiosys

CytoBioscience, Inc.

San Antonio, TX · Mar 26, 2015 → Mar 16, 2018 · 6 filings
  • Mar 16, 2018 · D/A · $1,530,000 sold of $1,530,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 15, 2018 · D · $1,530,000 sold of $1,530,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 23, 2018 · D/A · $15,821,845 sold of $21,821,845 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 22, 2018 · D/A · $15,821,845 sold of $21,821,845 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 10, 2016 · D/A · $15,821,845 sold of $21,821,845 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 26, 2015 · D · $6,637,345 sold of $18,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $15.8M from 11 investors (100% of the $1.53M target) as of the latest filing. Alan is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BM
Biotechnology · group: Targeted Technology

BI02 MEDICAL, INC.

Helotes, TX · Apr 15, 2010 → Mar 31, 2017 · 7 filings
  • Mar 31, 2017 · D · $1,500,000 sold of $8,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 10, 2015 · D · $4,000,000 sold of $10,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 14, 2014 · D · $5,873,199 sold of $7,549,615 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 5, 2012 · D · $11,921,539 sold of $20,000,000 · 30 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 11, 2011 · D · $4,576,769 sold of $5,220,000 · 66 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 4, 2010 · D/A · $6,697,942 sold of $7,500,000 · 57 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 15, 2010 · D · $6,546,741 sold of $7,500,000 · 51 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $11.9M from 66 investors (100% of the $8M target) as of the latest filing. Alan is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BV
Other · group: Targeted Technology

Bluegrass Vascular Technologies, Inc.

San Antonio, TX · Nov 13, 2014
  • Nov 13, 2014 · D · $4,800,000 sold of Indefinite · 25 investors · min. $10,000 · role: Director EDGAR ↗

Raised $4.8M from 25 investors as of the latest filing. Alan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TT
Pooled Investment Fund · group: Targeted Technology

Targeted Technology Fund II, LP

San Antonio, TX · Nov 7, 2013 → Oct 15, 2014 · 2 filings
  • Oct 15, 2014 · D/A · $37,200,000 sold of $50,000,000 · 83 investors · min. $100,000 · role: Director, Promoter (Equity owner of the general partner. Has approval rights.) EDGAR ↗
  • Nov 7, 2013 · D · $20,005,000 sold of $50,000,000 · 34 investors · min. $100,000 · role: Director, Promoter (Equity owner of the general partner. Has approval rights.) EDGAR ↗

Raised $37.2M from 83 investors (74% of the $50M target) as of the latest filing. Alan is listed as director, promoter on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VC
Pharmaceuticals · group: Targeted Technology

Viroxis Corp

San Antonio, TX · Jan 14, 2010 → Apr 22, 2013 · 6 filings
  • Apr 22, 2013 · D/A · $7,795,000 sold of $7,795,000 · 43 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 11, 2013 · D/A · $7,795,000 sold of $7,795,000 · 43 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 8, 2012 · D · $1,010,000 sold of $10,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 18, 2010 · D · $1,250,000 sold of $2,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 26, 2010 · D · $772,685 sold of $1,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 14, 2010 · D · $500,700 sold of $500,700 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $7.79M from 43 investors (100% of the $7.79M target) as of the latest filing. Alan is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

TT
Pooled Investment Fund · group: Targeted Technology

TARGETED TECHNOLOGY FUND I, LP

San Antonio, TX · Jul 14, 2009 → Jan 13, 2010 · 5 filings
  • Jan 13, 2010 · D/A · $11,235,000 sold of $50,000,000 · 48 investors · min. $10,000 · role: Director, Promoter (Organizer of the Issuer and Manager of Incyte Venture Partners LLC) EDGAR ↗
  • Dec 23, 2009 · D/A · $8,740,000 sold of $50,000,000 · 31 investors · min. $10,000 · role: Director, Promoter (Organizer of the Issuer and Manager of Incyte Venture Partners LLC) EDGAR ↗
  • Nov 2, 2009 · D/A · $7,455,000 sold of $50,000,000 · 25 investors · min. $80,000 · role: Director, Promoter (Organizer of the Issuer and Manager of Incyte Venture Partners LLC) EDGAR ↗
  • Sep 8, 2009 · D/A · $6,605,000 sold of $50,000,000 · 22 investors · min. $80,000 · role: Director, Promoter (Organizer of the Issuer and Manager of Incyte Venture Partners LLC) EDGAR ↗
  • Jul 14, 2009 · D · $4,855,000 sold of $50,000,000 · 13 investors · min. $80,000 · role: Director, Promoter (Organizer of the Issuer and Manager of Incyte Venture Partners LLC) EDGAR ↗

Raised $11.2M from 48 investors (22% of the $50M target) as of the latest filing. Alan is listed as director, promoter on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Alan Dean — AL, 1 issuer, Aug 25, 2010 → Aug 25, 2010 · no shared issuer

People around Alan 23

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

IG
Management entity

Incyte General Partner, LP

Promoter · 5 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

IV
Management entity

Incyte Venture Partners LLC

Promoter · 5 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

HC
Management entity

H CFB Interests, LLC

Director, Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

HF
Management entity

H Frashier Investments, Ltd.

Director, Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

TF
Management entity

Targeted Fund Partners LLC

Director, Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

PC
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Castella

Director, Promoter, Executive Officer · 24 shared filings (4 issuers) · also on 5 other issuers

Paul Castella is on 9 issuers in total — a repeat sponsor. Their page lists every one.

IC
No photo found yet (own website and image search run after this page is viewed)
Person

Ian Clements

Executive Officer, Director, Promoter · 14 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Alan Dean. Their page shows their other deals.

CB
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Banas

Director, Promoter, Executive Officer · 12 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Alan Dean. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

James F. Traa

Promoter, Director · 8 shared filings (3 issuers)

Listed on the same filings as Alan Dean. Their page shows their other deals.

LA
No photo found yet (own website and image search run after this page is viewed)
Person

Luis Angel

Executive Officer, Director, Promoter · 7 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

James R. Garvin

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

LG
No photo found yet (own website and image search run after this page is viewed)
Person

Lukin T. Gilliland, Jr.

Promoter · 5 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

John Creecy

Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Alan Dean. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Bailey

Director · 4 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

GF
No photo found yet (own website and image search run after this page is viewed)
Person

Gary Frashier

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Alan Dean. Their page shows their other deals.

CB
No photo found yet (own website and image search run after this page is viewed)
Person

Cathy Burzik

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Alan Dean. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Goodrich

Director · 2 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Savas

Director, Promoter · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Alan Dean. Their page shows their other deals.

CL
No photo found yet (own website and image search run after this page is viewed)
Person

Corey Levenson

Director, Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

JE
No photo found yet (own website and image search run after this page is viewed)
Person

John Elwood

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Alan Dean. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Coleman

Director · 1 shared filing (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

James Clifton

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Alan Dean. Their page shows their other deals.

The team behind the deals

TT
Sponsor group

Targeted Technology

9 issuers · 37 filings · $64.9M reported sold · 2009–2026

One team, 9 deal companies. Alan Dean is listed on 5 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Alan Dean.

S
Sponsor group

Stembiosys

2 issuers · 15 filings · $1.53M reported sold · 2013–2020

One team, 2 deal companies. Alan Dean is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Alan Dean.

Registrations and other filings

Adviser registration (Form ADV)

None of the 6 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Alan Dean by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 6 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Alan Dean is listed on, as found in their SEC filings (Form C, Reg A, Form ADV, EDGAR profile) or on the sponsor's own site; none belongs to the person unless the sponsor's site says so. Checked Oct 24, 2026.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Antonio, TX). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Found on the sponsor's own site

stembiosys.com ↗ found on CytoBioscience, Inc. (stembiosys.com — same registered sponsor family (group "Stembiosys"); known from issuer CIK 1568861 (form-c))

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Texas re:SearchTX court records ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Texas Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Alan Dean appears on a new Form D, or when a court case or SEC action is matched to them. See plans →